Quick Research
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Cell Culture Medium
- Cell Culture Reagent
- Cell Function Assay
- Cell Health Detection Kit
- Cell Line
- Others
- Primary Cell
- Serum
- Service
- Transfection Reagent
Country
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Guyana
- Hungary
- India
- Iran
- Ireland
- Israel
- Italy
- Japan
- Kenya
- Korea
- Kuwait
- Luxembourg
- Madagascar
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Niger
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Russian Federation
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 27,713 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
Original research: Low molecular weight heparin synergistically enhances the efficacy of adoptive and anti-PD-1-based immunotherapy by increasing lymphocyte infiltration in colorectal cancer (2023-08-18)
Journal: Journal for ImmunoTherapy of Cancer (2023) IF: 10.9Products Cited: CT26.WT Cells Line -
Loss of ADAR1 in macrophages in combination with interferon gamma suppresses tumor growth by remodeling the tumor microenvironment (2023-11-01)
Journal: Journal for ImmunoTherapy of Cancer (2023) IF: 10.9Products Cited: Hank's Balanced Salt Solution (HBSS), with calcium, magnesium, without phenol red, SVEC4-10 Cells Line, Penicillin-Streptomycin Solution, 100 ×, Human Umbilical Vein Endothelial Cells -
Original research: Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination (2023-12-01)
Journal: Journal for ImmunoTherapy of Cancer (2023) IF: 10.9Products Cited: PC-9 Cells Line -
Original research: CXCL10 and Nrf2-upregulated mesenchymal stem cells reinvigorate T lymphocytes for combating glioblastoma (2023-12-06)
Journal: Journal for ImmunoTherapy of Cancer (2023) IF: 10.9Products Cited: Mouse Bone Marrow Mesenchymal Stem cells, GL261 Cells Line -
Low levels of tenofovir in breast milk support breastfeeding in HBV-infected mothers treated with tenofovir disoproxil fumarate (2023-01-14)
Journal: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2023) IF: 10.8Products Cited: MCF 10A Cells Line -
HIF-1 inhibitor-based one-stone-two-birds strategy for enhanced cancer chemodynamic-immunotherapy (2023-03-21)
Journal: JOURNAL OF CONTROLLED RELEASE (2023) IF: 10.8Products Cited: 4T1 Cells Line -
Microneedle-assisted vaccination combined with autophagy regulation for antitumor immunotherapy (2023-04-24)
Journal: JOURNAL OF CONTROLLED RELEASE (2023) IF: 10.8Products Cited: B16 Cells Line -
Cuproptosis-immunotherapy using PD-1 overexpressing T cell membrane-coated nanosheets efficiently treats tumor (2023-09-09)
Journal: JOURNAL OF CONTROLLED RELEASE (2023) IF: 10.8Products Cited: CTLL-2 Cells Line, 4T1 Cells Line -
Negatively charged bladder acellular matrix loaded with positively charged adipose-derived mesenchymal stem cell-derived small extracellular vesicles for bladder tissue engineering (2023-11-18)
Journal: JOURNAL OF CONTROLLED RELEASE (2023) IF: 10.8Products Cited: Human Bone Marrow Mesenchymal Stem Cells Adipogenic Differentiation Medium, Rat Bladder Smooth Muscle Cells, Human Bone Marrow Mesenchymal Stem Cells Osteogenic Differentiation Medium, Human Umbilical Vein Endothelial Cells, PC-12 (Low differentiation) Cells Line, Human Bone Marrow Mesenchymal Stem Cells Chondrogenic Differentiation Medium -
Inducing in situ M2 macrophage polarization to promote the repair of bone defects via scaffold-mediated sustained delivery of luteolin (2023-12-18)
Journal: JOURNAL OF CONTROLLED RELEASE (2023) IF: 10.8Products Cited: Rat Bone Marrow Mesenchymal Stem cells, RAW 264.7 Cells Line, MEMα, DMEM(High glucose)
